Modeling‐Based Bone Formation After 2 Months of Romosozumab Treatment: Results From the <scp>FRAME</scp> Clinical Trial

MLA

Stéphane Horlait, et al. “Modeling‐Based Bone Formation After 2 Months of Romosozumab Treatment: Results From the FRAME Clinical Trial.” Journal of Bone and Mineral Research, vol. 37, Nov. 2021, pp. 36–40. EBSCOhost, https://doi.org/10.1002/jbmr.4457.

APA

Stéphane Horlait, Donald Betah, Jacques P. Brown, Cesar Libanati, Yifei Shi, Rogely W. Boyce, Erik Fink Eriksen, Pascale Chavassieux, & Roland Chapurlat. (2021). Modeling‐Based Bone Formation After 2 Months of Romosozumab Treatment: Results From the FRAME Clinical Trial. Journal of Bone and Mineral Research, 37, 36–40. https://doi.org/10.1002/jbmr.4457

Chicago

Stéphane Horlait, Donald Betah, Jacques P. Brown, Cesar Libanati, Yifei Shi, Rogely W. Boyce, Erik Fink Eriksen, Pascale Chavassieux, and Roland Chapurlat. 2021. “Modeling‐Based Bone Formation After 2 Months of Romosozumab Treatment: Results From the FRAME Clinical Trial.” Journal of Bone and Mineral Research 37 (November): 36–40. doi:10.1002/jbmr.4457.